Use this URL to cite or link to this record in EThOS:
Title: Investigation of VPS33B deficiency in mouse and man
Author: Smith, Holly
ISNI:       0000 0004 2730 0601
Awarding Body: University of Birmingham
Current Institution: University of Birmingham
Date of Award: 2012
Availability of Full Text:
Access from EThOS:
Access from Institution:
Arthrogryposis, renal dysfunction and cholestasis (ARC) syndrome is a severe multisystem disorder caused by mutations in VPS33B and VIPAR. A splice site mutation, VPS33B c.1225+5 G>C, was identified in a patient with attenuated ARC phenotype. Modelling of this mutation and missense mutations indicated that VPS33B-VIPAR interaction and co-localisation at recycling-endosome like structures is necessary for their function. Development of a murine ARC model began with ubiquitous removal of Vps33b, and in parallel, its homologue Vps33a. Both resulted in embryonic lethality between E7.5 and E8.5. A good ARC phenocopy was obtained the liver specific Vps33b knockout, Vps33b\(^{fl/fl}\)- AlpfCre. Bile acid levels were increased in comparison to control and the apical proteins CEA and BSEP were mislocalised, with the distribution similar to that in ARC livers. In contrast, a Vps33b\(^{fl/fl}\)-Pf4Cre mouse did not result in a good ARC platelet phenocopy, with α-granules found present. They did however present with a mild platelet phenotype, with defects in stable aggregate formation under shear conditions and deficiencies in the α- granule proteins VWF and PF4, giving possible insights into the bleeding diathesis in patients. In conclusion, this work has produced suitable ARC models for further study of Vps33b function and provides a platform for the future development of gene therapy and drug treatments.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID:  DOI: Not available
Keywords: QH426 Genetics ; RC Internal medicine